Needham cuts Lumentum price target to $800 from $1,040, keeps Buy

A price target cut paired with a maintained Buy is a classic recalibration rather than a change of thesis, and the size of the trim suggests Needham is resetting expectations rather than signaling deterioration in the underlying story. The signal that matters is the gap between the firm's stance and its own numbers: conviction in the name persists even as the implied upside narrows. Whether that Buy rating holds through the next round of estimate revisions is the open question.